醫療用品套裝市場規模、佔有率和成長分析：按產品類型、應用、最終用戶、材料、滅菌方式和地區分類 - 產業預測，2026-2033 年

2024 年全球管理套裝市場價值為 23.8 億美元，預計到 2025 年將成長至 25.3 億美元，到 2033 年將成長至 40.9 億美元，預測期（2026-2033 年）複合年成長率為 6.2%。

全球輸液器市場涵蓋了用於在各種醫療機構（包括醫院、輸液中心和居家照護）輸注體液和藥物的關鍵組件，例如輸液管、穿刺器和歧管。無污染藥物輸送的重要性日益凸顯，尤其是在化療和生物製藥等療法中，這推動了市場的發展。此外，對整合感測器和數位連接功能的智慧輸液器的需求不斷成長，提高了即時流量監測能力。這使得臨床醫生能夠快速檢測阻塞和劑量差異，從而減少不利事件並縮短住院時間。家庭生物製藥療法的興起也對方便用戶使用、防篡改的設計提出了更高的要求，這為利基供應商在不斷變化的醫療保健需求中贏得市場佔有率創造了機會。

全球輸液器市場按產品類型、應用、最終用戶、材質、無菌狀態和地區進行細分。依產品類型分類，可分為重力輸液器、幫浦輸液器、輸血器和延長輸液器。依應用分類，可分為靜脈輸液、輸血、化療和腸外營養。按最終用戶分類，可分為醫院、門診手術中心和居家醫療。依材質分類，可分為聚氯乙烯（PVC）和非聚氯乙烯（非PVC）材質。依無菌狀態分類，可分為無菌產品及非無菌產品。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球行政辦公設備市場成長要素

醫療機構正日益採用標準化管理資料集，以加強臨床、研究和行政部門之間的資料交換，並促進病患資訊、檢體元資料和分析結果的共用。這種增強的互通性最大限度地減少了人工匹配所需的時間，降低了出錯機率，加快了決策流程，並最終提高了整體效率。此外，它還促進了更多協作。隨著相關人員認知到統一資料結構的策略優勢，對綜合管理資料集解決方案的需求不斷成長，推動了市場擴張，並促進了全球不同醫療生態系統中整合能力的進一步創新，而不受地域差異的影響。

全球行政管理市場中的限制因素

全球管理套件市場面臨著許多限制因素，其中之一是購置、客製化和實施一套完整的管理套件平台需要大量的初始投資。這些投資包括軟體許可、必要的硬體基礎設施和專業服務。許多機構，尤其是小規模研究機構和新興市場的新興企業，都面臨預算有限的困境，這阻礙了此類專案的資金投入。因此，財務風險成為主要考慮因素，常常導致企業推遲甚至放棄採用先進的解決方案，最終阻礙了市場滲透。這種成本敏感度也使得市場快速擴張變得困難，因為相關人員往往優先考慮基本功能而非可選的技術升級。

全球管理引領市場趨勢

全球輸液器市場正經歷顯著的變革，這主要得益於再生醫學的發展，尤其是細胞療法和組織工程產品的整合。為了滿足日益成長的專用輸液器需求，製造商正致力於開發密封性強、剪切力低的裝置，以優先保障細胞活力、最大限度減少污染並確保生物製藥的精準輸送。這種發展趨勢促使供應商採用模組化套件的概念，這些套件能夠與生物反應器和輸液泵無縫整合，從而簡化先進醫院和研究機構的工作流程。因此，市場正從傳統藥物轉向更有價值、更個人化的治療策略，加速了這些策略在各種醫療機構中的臨床應用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球行政辦公套裝市場規模：依產品類型分類

• 重力式給藥裝置
• 泵浦式給藥裝置
• 輸血管理包
• 擴充管理套裝

全球行政辦公設備市場規模：依應用領域分類

• 靜脈輸液療法
• 輸血
• 化療
• 腸外營養

全球行政管理套裝市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 家庭醫療保健

全球行政辦公套裝市場規模：依材料分類

• PVC
• 不含聚氯乙烯

全球行政管理套裝市場規模：依滅菌狀態分類

• 已滅菌
• 非無菌

全球行政辦公設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Becton, Dickinson and Company
• B. Braun SE
• Baxter International Inc.
• ICU Medical, Inc.
• Fresenius SE & Co. KGaA
• Nipro Corporation
• Terumo Corporation
• Smiths Group plc
• Cardinal Health, Inc.
• Vygon SAS
• Poly Medicure Limited
• Romsons Group Pvt. Ltd.
• Angiplast Pvt. Ltd.
• Medline Industries, LP
• ConvaTec Group Plc
• Moog Inc.
• Well Lead Medical Co., Ltd.
• Grevotex Co., Ltd.
• Renax Biomedical Technology Co., Ltd.
• Kapsam Health Products Ltd.

結論與建議

Global Administration Sets Market size was valued at USD 2.38 Billion in 2024 and is poised to grow from USD 2.53 Billion in 2025 to USD 4.09 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global administration sets market encompasses essential components such as tubing, spike sets, and manifolds utilized for fluid and medication delivery in various healthcare settings, including hospitals, infusion centers, and home care. The increasing emphasis on contamination-free drug delivery, particularly for treatments like chemotherapy and biologics, is driving market significance. Moreover, the rising demand for smart administration sets integrated with sensors and digital connectivity enhances real-time flow monitoring, enabling clinicians to swiftly detect occlusions or dosage discrepancies, thereby reducing adverse events and potentially shortening hospital stays. Additionally, the growing trend of home-based biologic therapies necessitates user-friendly and tamper-resistant designs, offering opportunities for niche suppliers to capture market share amid evolving healthcare needs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Administration Sets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Administration Sets Market Segments Analysis

The global administration sets market is segmented by product type, application, end user, material, sterility and region. Based on product type, the market is segmented into Gravity Administration Sets, Pump Administration Sets, Blood Administration Sets and Extension Administration Sets. Based on application, the market is segmented into Intravenous Therapy, Blood Transfusion, Chemotherapy and Parenteral Nutrition. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Home Healthcare. Based on material, the market is segmented into PVC and Non-PVC. Based on sterility, the market is segmented into Sterile and Non-Sterile. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Administration Sets Market

Organizations are increasingly embracing standardized administration sets to enhance data exchange across clinical, research, and operational sectors, facilitating smoother sharing of patient information, sample metadata, and analytical outputs. This improved interoperability minimizes the time spent on manual reconciliations, reduces the likelihood of errors, and accelerates decision-making processes, ultimately boosting overall efficiency. Furthermore, it fosters more coordinated collaborative initiatives. As stakeholders recognize the strategic advantages of having a unified data structure, the demand for comprehensive administration set solutions is on the rise, driving market expansion and encouraging further innovation in integration capabilities across various healthcare ecosystems globally, regardless of regional visibility.

Restraints in the Global Administration Sets Market

The Global Administration Sets market faces significant constraints due to the substantial initial investment required for the acquisition, customization, and implementation of comprehensive administration set platforms. This investment encompasses software licenses, necessary hardware infrastructure, and professional services. Many organizations, particularly smaller research institutions and newer players in emerging markets, grapple with limited budgets that hinder their ability to allocate funds toward these projects. Consequently, the perceived financial risk looms large, often resulting in delayed adoption or the forgoing of advanced solutions altogether, which ultimately hampers market penetration. This sensitivity to costs complicates rapid expansion, as stakeholders tend to prioritize essential operations over optional technology upgrades.

Market Trends of the Global Administration Sets Market

The Global Administration Sets market is experiencing a significant shift driven by the integration of regenerative medicine, particularly cell-based therapies and tissue-engineered products. As manufacturers strive to meet the growing demand for specialized administration sets, there is a focus on developing closed-system, low-shear devices that prioritize cell viability and minimize contamination while ensuring precise dosing for biologics. This evolution has led suppliers to adopt modular kit concepts that seamlessly connect with bioreactors and infusion pumps, promoting streamlined workflows in advanced hospitals and research facilities. Consequently, the market is transitioning away from traditional pharmaceuticals and embracing higher-value, personalized treatment strategies, thereby accelerating clinical adoption across various healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Administration Sets Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gravity Administration Sets
• Pump Administration Sets
• Blood Administration Sets
• Extension Administration Sets

Global Administration Sets Market Size by Application & CAGR (2026-2033)

• Market Overview
• Intravenous Therapy
• Blood Transfusion
• Chemotherapy
• Parenteral Nutrition

Global Administration Sets Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Home Healthcare

Global Administration Sets Market Size by Material & CAGR (2026-2033)

• Market Overview
• PVC
• Non-PVC

Global Administration Sets Market Size by Sterility & CAGR (2026-2033)

• Market Overview
• Sterile
• Non-Sterile

Global Administration Sets Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End User, Material, Sterility)
  • US
  • Canada
• Europe (Product Type, Application, End User, Material, Sterility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End User, Material, Sterility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End User, Material, Sterility)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User, Material, Sterility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vygon SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Romsons Group Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Angiplast Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, LP
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConvaTec Group Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grevotex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renax Biomedical Technology Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kapsam Health Products Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations